156 related articles for article (PubMed ID: 38592206)
1. A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches.
Gisca T; Munteanu IV; Vasilache IA; Melinte-Popescu AS; Volovat S; Scripcariu IS; Balan RA; Pavaleanu I; Socolov R; Carauleanu A; Vaduva C; Melinte-Popescu M; Adam AM; Adam G; Vicoveanu P; Socolov D
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592206
[TBL] [Abstract][Full Text] [Related]
2. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
[TBL] [Abstract][Full Text] [Related]
3. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
4. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N
J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802
[TBL] [Abstract][Full Text] [Related]
5. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
6. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
[TBL] [Abstract][Full Text] [Related]
7. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
8. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
[TBL] [Abstract][Full Text] [Related]
9. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract][Full Text] [Related]
10. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A
J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].
Zeng X; Li J; Kang LN; Yan LP; He Z; Liao GD; Xi MR; Chen MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):896-903. PubMed ID: 36224694
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia.
Samarawardana P; Dehn DL; Singh M; Franquemont D; Thompson C; Gaido L; Torkko KC; Homer P; Burke S; Titmus MA; Nayi V; Shroyer KR
Cancer Cytopathol; 2010 Jun; 118(3):146-56. PubMed ID: 20544710
[TBL] [Abstract][Full Text] [Related]
13. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
[TBL] [Abstract][Full Text] [Related]
14. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
16. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
17. Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894462
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of P16/Ki67 (CINtecPlus) and L1-capsid compared with HPV-genotyping in cervical cytology in women ≥35 years old focusing on patients with atypical squamous cells of undetermined significance.
Abbas M; Erduran I; De Jonge J; Bettendorf O
Oncol Lett; 2022 Jul; 24(1):242. PubMed ID: 35720497
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
[TBL] [Abstract][Full Text] [Related]
20. HPV genotyping and p16÷Ki-67 dual staining in the detection of high-grade cervical lesion in patients with LSIL on Pap smear.
Moleriu LC; Sas I; RaŢiu AC; Margan MM; Secoşan CA; Ilina RŞ; Horhat FG; Stana LG; Grigoraş D; Pirtea LC
Rom J Morphol Embryol; 2017; 58(2):433-437. PubMed ID: 28730227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
